The Dales Report | Trade to Black

By Dales Media Group

We are a business news platform that provides the latest and best insight into the stories that make headlines worldwide.

From cannabis to psychedelics, crypto and more, we give institutional and reta... more

5

77 ratings

Download on the App Store

Download on the App Store

Get it on Google Play

FAQs about The Dales Report | Trade to Black:

How many episodes does The Dales Report | Trade to Black have?

The podcast currently has 297 episodes available.

The Dales Report | Trade to Black episodes:

January 30, 2024 Why This Quarter Could Be Vital for Cybin's FDA Milestones! | TDR Exclusive
Welcome to our latest TDR exclusive! In this episode with Doug Drysdale, CEO of Cybin we get into their groundbreaking developments in mental healthcare, including FDA clearance for a Phase 2a study of CYB004 in Generalized Anxiety Disorder, the positive impact of CYB003 on MADRS scores, and the future of psychedelic therapies in the industry. Stay tuned for exclusive insights into the evolving landscape of mental health treatments and Cybin's mission to revolutionize the field.
Guest: Doug Drysdale, CEO of Cybin
🔥 Join us for an in-depth interview with Cybin Inc., where we explore groundbreaking developments in mental healthcare and psychedelic treatments!
🧠 Learn about Cybin's FDA clearance for the Phase 2a study of CYB004 in Generalized Anxiety Disorder (GAD) and its mission to revolutionize mental healthcare.
💊 Discover the positive impact of CYB003 on MADRS scores, its significance in the market, and safety considerations.
🌌 Gain insights into Phase 1 studies of proprietary deuterated DMT molecules CYB004 and SPL028, and their role in safer and more effective mental health treatments.
💡 Discuss industry inflection points, potential legislative changes, and the impact of FDA decisions on psychedelic therapies.
📅 Get an exclusive timeline for CYB004's Phase 2a study in GAD and other near-term catalysts in 2024!
Stay tuned for insights into the future of mental healthcare and Cybin Inc.'s exciting developments! Subscribe now! 🌟 #MentalHealth #PsychedelicTherapies #CybinInc #FDAApproval #Innovation
...more
22min
January 24, 2024 Matt Zorn: The Lawyer Who Beat The DEA (Explained) | TDR Exclusive
On the TDR "Cannabis Exclusive Podcast" today we interview lawyer Matt Zorn. Get ready for a deep dive comprehensive exploration of the recently released drug policy report that's making waves in the legal and medical communities. Join us as we dissect the report's implications and unveil crucial insights into the DEA's actions and their potential impact on the industry.
Guest: Matthew C. Zorn, Partner at Yetter Coleman
https://www.yettercoleman.com/our-peo...
Highlights:
📜 Unveiling the Leaked Document: Learn how this confidential report became public knowledge and why it's essential for everyone to understand.
🏛️ Legal Hurdles and Defenses: Dive into the legal intricacies surrounding the report and discover how it could shape the future of drug policy.
🌿 Medical Use Criteria: Understand the significance of the report's criteria for accepted medical use, especially for substances like psilocybin.
🚀 Industry Impact: Explore the potential consequences for the drug industry and what this means for its stakeholders.
🤝 A Conversation with Legal Expert: Gain valuable insights from our guest speaker, an expert in drug policy and law.
💡 Path Forward: Delve into the possibilities and uncertainties surrounding the DEA's actions and the rescheduling debate.
Join us on this enlightening journey through the depths of drug policy and legal matters. Don't miss this opportunity to stay informed and be part of the conversation shaping the future of drug policy in the United States!
...more
26min
January 24, 2024 What Lies Ahead For The Cannabist Company's New CEO, David Hart
On the "Cannabis Exclusive Podcast" today we interview David Hart. David has been appointed as the new CEO of The Cannabist Company Holdings inc. He has been with the company since 2018 and has played a key role in its growth and success. He aims to continue creating opportunities for team members and driving financial performance.
Cannabist Company Holdings Inc OTCMKTS: CBSTF
Highlights
🌟 David Hart has been appointed as the new CEO of the Cannabis company Holdings.
🌟 His biggest achievement is creating a platform that allows people to grow their careers within the company.
🌟 The culture within the organization is focused on leveraging their portfolio of assets and moving faster to find cost synergies.
🌟 The company’s focus is on stabilizing and expanding their presence in markets with organic growth potential.

...more
26min
January 24, 2024 What Is The 280E Tax Loophole? | TDR Exclusive
TDR Cannabis Exclusive: MBO Ventures and the ESOP 280E Tax Loophole explained. Darren Gleeman, the Managing Partner of MBO Ventures, joins TDR Cannabis for an exclusive interview.
Gleeman sheds light on Employee Stock Ownership Plans (ESOPs) and their potential to help cannabis companies avoid the dreaded 280e tax code. Discover the inner workings of ESOPs, their structure, and the benefits they offer to both businesses and employees. Gain insights into how ESOPs can play a crucial role in building a thriving cannabis industry.
📚 Top Topics Covered:
1️⃣ Understanding ESOPs: Gleeman walks us through the concept of ESOPs, which provide an alternative way for business owners to sell their companies.
2️⃣ The Tax Subsidy Advantage: Learn about the government incentives behind selling to employees and how ESOPs can help employees gain equity and ownership.
3️⃣ Deferring Capital Gains: Discover the significant tax benefits of selling a company through an ESOP, including the deferral of capital gains tax, leading to substantial savings.
4️⃣ ESOPs in the Cannabis Industry: Gleeman explains how ESOPs can be structured specifically for cannabis businesses, addressing the unique challenges posed by the industry.
5️⃣ Public vs. Private Companies: Gain insights into the differences and limitations of implementing ESOPs in publicly traded cannabis companies versus private companies.
6️⃣ A Game-Changing Solution: Explore how ESOPs can transform company culture, instill a sense of ownership among employees, and potentially enhance retention rates.
7️⃣ The Future of ESOPs in Cannabis: Gleeman shares his growth trajectory and projections for the industry, highlighting opportunities for private companies to leverage ESOPs.
🌟 Don't miss this eye-opening interview as Darren Gleeman provides a deep dive into ESOPs and their potential to reshape the cannabis landscape. Join us for a discussion that could change the way you think about taxes and ownership. 🌟
...more
30min
January 24, 2024 "These Stocks Have Potential To Go Through The Roof" AdvisorShares MSOS, Dan Ahrens
On the "Cannabis Exclusive Podcast" today we interview Dan S. Ahrens, Managing Director & Chief Operating Officer of AdvisorShares. In this episode, we dive deep into the exciting world of cannabis investments, focusing on the holdings in the AdvisorShares Pure US Cannabis ETF (NYSEARCA: MSOS).
📈 Discover the impact of increased trading volume and changing investor sentiment in the cannabis market in 2024.
🏛️ Gain insights into institutional involvement and their strategies ahead of a potential rescheduling announcement.
🌱 Explore the growth plans of prominent cannabis companies and their impact on MSOS.
...more
36min
January 24, 2024 How Cannabis Rescheduling Could Impact (Growth) At NewLake Capital Partners?
In this exclusive interview on The Dales Report, hosts Shadd Dales and Anthony Varrell speak with featured guest Anthony Coniglio, CEO of NewLake Capital Partners (OTC: NLCP), a leading provider of real estate capital to state-licensed cannabis operators.
🎯 NewLake Capital Partners Company Performance (Q4 2023):
💥Dividend Yield: Impressive 12%
💥Committed Capital: $427 million
💥Property Portfolio: 31 properties across 12 states
Anthony provides insights into the company's growth strategy going into 2024, including managing their portfolio risk, pursuing quality transactions, and further telling NewLake's story to institutional investors.
Explore must-know broader industry trends, including potential federal cannabis legislation, market conditions like interest rate cuts, and predictions for growth in 2024. They talk about opportunities in newly legal states like New York and Ohio, consolidation of licenses, and plans to combat the illicit market.
It's an in-depth look at the cannabis real estate sector. Whether you're an investor looking for dividend income or an operator needing customized sale-leaseback financing, this is a can't miss discussion on the state of cannabis capital and what's next for the industry.
...more
33min
January 24, 2024 Jesse Channon's Bold 2024 Strategic Vision | TDR Exclusive
Welcome to our latest TDR cannabis exclusive! In this episode, we dive deep into The Cannabist Company with the new leadership change. Jesse Channon, President of The Cannabist Company discusses their vision and strategy for the future. Learn about the culture within The Cannabist Company, the changing regulatory landscape, the importance of safe products, and their plans to streamline operations for a transformative 2024 and beyond. Join us for an insightful conversation on the exciting trends and opportunities in the cannabis industry.
...more
30min

FAQs about The Dales Report | Trade to Black:

How many episodes does The Dales Report | Trade to Black have?

The podcast currently has 297 episodes available.

More shows like The Dales Report | Trade to Black

Blunt Business by Cannabis Radio

Blunt Business

40 Listeners

Modern Wisdom by Chris Williamson

Modern Wisdom

3,765 Listeners

Mining Stock Daily by Trevor Hall

Mining Stock Daily

95 Listeners

The Pomp Podcast by Anthony Pompliano

The Pomp Podcast

1,835 Listeners

The Cannabis Investing Podcast by Seeking Alpha

The Cannabis Investing Podcast

204 Listeners

Cannabis Investing Network by CIN Podcast

Cannabis Investing Network

70 Listeners

The Prof G Pod with Scott Galloway by Vox Media Podcast Network

The Prof G Pod with Scott Galloway

5,434 Listeners

The Memo by Howard Marks by Oaktree Capital Management

The Memo by Howard Marks

401 Listeners

The Dime by Bryan Fields & Kellan Finney

The Dime

104 Listeners

Huberman Lab by Scicomm Media

Huberman Lab

28,589 Listeners

Honestly with Bari Weiss by The Free Press

Honestly with Bari Weiss

8,598 Listeners

On The Tape with Danny Moses by RiskReversal Media

On The Tape with Danny Moses

155 Listeners

High Spirits: The Cannabis Business Podcast by AnnaRae Grabstein and Ben Larson

High Spirits: The Cannabis Business Podcast

6 Listeners

Higher Exchanges by Higher Exchanges

Higher Exchanges

11 Listeners

Prof G Markets by Vox Media Podcast Network

Prof G Markets

1,164 Listeners